Chronic Pain Management

Name: Chronic Pain Management
Uploaded: 2024-07-28 22:02:18
Description: Hemp cannabinoids and medical cannabis offer a natural and effective solution, providing pain relief with minimal side effects and additional benefits like improved sleep and reduced anxiety.

Education Webinars Chronic Pain Management

Hemp cannabinoids and medical cannabis offer a natural and effective solution, providing pain relief with minimal side effects and additional benefits like improved sleep and reduced anxiety.

Integrate Powerful Hemp Cannabinoids into your Healthcare Practice

Learn from leading cannabis clinician Bonni Goldstein, MD and grow your practice revenues through our lab-tested hemp extract marketplace, while providing an exclusive medical discount to your patients. For a limited time, our platform is free for licensed US healthcare practitioners only.

With your free account, you'll get access to this educational video and so much more!

Learn more Create your free account

View Sources

Abuhasira, R., Schleider, L. B. L., Mechoulam, R., & Novack, V. (2018). Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine, 49, 44–50.

Andreae, M. H., Carter, G. M., Shaparin, N., Suslov, K., Ellis, R. J., Ware, M. A., … Sacks, H. S. (2015). Inhaled cannabis for chronic neuropathic pain: A meta-analysis of individual patient data. The Journal of Pain, 16(12), 1221–1232.

Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006). Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology, 45(1), 50–52.

Bonin, E. A., Lejeune, N., Szymkowicz, E., Bonhomme, V., Martial, C., Gosseries, O., … Thibaut, A. (2023). Assessment and management of pain/nociception in patients with disorders of consciousness or locked-in syndrome: A narrative review. Frontiers in Systems Neuroscience, 17, 1112206.

Bouchet, C. A., & Ingram, S. L. (2020). Cannabinoids in the descending pain modulatory circuit: Role in inflammation. Pharmacology & Therapeutics, 209, 107495.

Capano, A., Weaver, R., & Burkman, E. (2020). Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: A prospective cohort study. Postgraduate Medicine, 132(1), 56–61.

Carey, L. M., Maguire, D. R., & France, C. P. (2023). Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys. Drug and Alcohol Dependence, 244, 109787.

Cohen, S. P., Vase, L., & Hooten, W. M. (2021). Chronic pain: An update on burden, best practices, and new advances. The Lancet, 397(10289), 2082–2097.

Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E., Soliman, N., & Rice, A. S. (2021). Cannabinoids, the endocannabinoid system, and pain: A review of preclinical studies. Pain, 162, S5–S25.

Frane, N., Stapleton, E., Iturriaga, C., Ganz, M., Rasquinha, V., & Duarte, R. (2022). Cannabidiol as a treatment for arthritis and joint pain: An exploratory cross-sectional study. Journal of Cannabis Research, 4(1), 47.

Freynhagen, R., et al. (2019). Current understanding of the mixed pain concept: A brief narrative review. Current Medical Research and Opinion, 35(6), 1011–1018.

Grenald, S. A., Young, M. A., Wang, Y., Ossipov, M. H., Ibrahim, M. M., Largent-Milnes, T. M., & Vanderah, T. W. (2017). Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. Neuropharmacology, 116, 59–70.

Gruber, S. A., Smith, R. T., Dahlgren, M. K., Lambros, A. M., & Sagar, K. A. (2021). No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms. Experimental and Clinical Psychopharmacology, 29(2), 147.

Gustavsen, S., Søndergaard, H. B., Linnet, K., Thomsen, R., Rasmussen, B. S., Sorensen, P. S., … Oturai, A. B. (2021). Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. Multiple Sclerosis and Related Disorders, 48, 102708.

Haddad, F., Dokmak, G., & Karaman, R. (2022). The efficacy of cannabis on multiple sclerosis-related symptoms. Life, 12(5), 682.

Hsieh, G. C., Pai, M., Chandran, P., Hooker, B. A., Zhu, C. Z., Salyers, A. K., … Meyer, M. D. (2011). Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. British Journal of Pharmacology, 162(2), 428–440.

Kluwe, L., Scholze, C., Schmidberg, L. M., Wichmann, J. L., Gemkov, M., Keller, M. J., & Farschtschi, S. C. (2023). Medical cannabis alleviates chronic neuropathic pain effectively and sustainably without severe adverse effect: A retrospective study on 99 cases. Medical Cannabis and Cannabinoids, 6(1), 89–96.

Li, M. H., Suchland, K. L., & Ingram, S. L. (2017). Compensatory activation of cannabinoid CB2 receptor inhibition of GABA release in the rostral ventromedial medulla in inflammatory pain. Journal of Neuroscience, 37(3), 626–636.

National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press. https://doi.org/10.17226/24625

Piper, B. J., Beals, M. L., Abess, A. T., Nichols, S. D., Martin, M. W., Cobb, C. M., & DeKeuster, R. M. (2017). Chronic pain patients’ perspectives of medical cannabis. Pain, 158(7), 1373–1379.

Safi, K., Sobieraj, J., Błaszkiewicz, M., Żyła, J., Salata, B., & Dzierżanowski, T. (2024). Tetrahydrocannabinol and cannabidiol for pain treatment—An update on the evidence. Biomedicines, 12(2), 307.

Sagy, I., et al. (2019). Safety and efficacy of medical cannabis in fibromyalgia. Journal of Clinical Medicine, 8(6), 807.

Schleider, L. B. L., Mechoulam, R., Lederman, V., Hilou, M., Lencovsky, O., Betzalel, O., … Novack, V. (2018). Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. European Journal of Internal Medicine, 49, 37–43.

Schuster, N. M., Wallace, M. S., Marcotte, T. D., Buse, D. C., Lee, E., Liu, L., & Sexton, M. (2024). Vaporized cannabis versus placebo for acute migraine: A randomized controlled trial. medRxiv.

Sherpa, M. L., Shrestha, N., Ojinna, B. T., Ravi, N., Kumar, V. S., Choday, S., … Elshaikh, A. O. (2022). Efficacy and safety of medical marijuana in migraine headache: A systematic review. Cureus, 14(12).

Überall, M. A. (2020). A review of scientific evidence for THC:CBD oromucosal spray (nabiximols) in the management of chronic pain. Journal of Pain Research, 399–410.

Ware, M. A., Wang, T., Shapiro, S., Collet, J. P., Boulanger, A., Esdaile, J. M., … O’Connell, C. (2015). Cannabis for the management of pain: Assessment of safety study (COMPASS). The Journal of Pain, 16(12), 1233–1242.

Collapse